Driving Clinical Success in Autoimmune & Allergic Disease Treatment via Mechanistic Insights, Biomarker Validation, Antigen Delivery, Clinical Trial Design & Even B-Cell/Cellular Tolerance
Uniting 100+ leaders from cutting-edge biotechs to global pharma, this summit delivers comprehensive insight across antigen selection, biomarker strategy, B-cell and cellular tolerance mechanisms, delivery platforms, and clinical trial execution.
The 2026 agenda spotlights late-stage data from Topas, Diamyd, and COUR; novel mRNA- LNP approaches from Moderna; integrated nanotherapeutics; and next-generation Treg and tolerance-restoring strategies. Key sessions explore central versus peripheral tolerance, and how gene and cell therapy are redefining therapeutic durability and safety.
Now in its ninth year, the 9th Antigen-Specific Immune Tolerance Summit remains the only end-to-end meeting dedicated to advancing antigen-specific immune tolerance. Join Pfizer, Moderna, AbbVie, Diamyd, COUR, and others as the field transitions from discovery and preclinical efforts to real-world clinical impact. Seize the opportunity to and play a central role in rewriting these transformative therapeutics
The interaction sessions with experts from different fields were impressive and enjoyable
Paul, Principal Scientist, AbbVie
The interaction sessions with experts from different fields were impressive and enjoyable
Paul, Principal Scientist, AbbVie
Really great meeting! All the talks were high quality and sufficiently diverse to cover a lot of different angles. Everything ran smoothly and was effective for our team both to learn from others and also promote our own work
Geoffrey, Chief Scientific Officer, Barinthus Bio
Explore the Full Event Guide
- Get a full overview of the agenda, speakers, and session topics in one place
- Share easily with your team to assess and mobilize interest
- Preview sessions containing brand-new data that we’ll be showcasing at the event
- Discover exclusive content from keynotes, academics, C-suite leaders, biotechs and biopharma executives
- Explore attendee benefits, exclusive event insights and anticipated audience metrics
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest ASIT industry breakthroughs and gain exclusive insights of the packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside leading drug developers and solution providers in this tight-knit community to ensure your brand is at the heart of the ASIT field.
Join Biopharma Experts
Be part of the hottest conversations with a specially curated audience of 100+ experts spanning from like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.